DLB

Dolby Laboratories, Inc.
$61.50
-0.91 (-1.46%)
Mkt Cap 5.85B
Volume 1,712,217
52W Range 48.26-73.78
Sector Technology
Beta 0.80
EPS (TTM) 2.38 USD
P/E Ratio 25.84
Revenue (TTM) 1.35B USD
Rev Growth (5Y) +3.0%
EPS Growth (5Y) +2.9%
AlphaVal · Fair Value
What we estimate one share is worth
$56.33
Overvalued weak signal
9.2% above fair value
Modeled from cash flows & growth.
AlphaQuality · Grade
How strong & durable the business is
B
Stable Earnings Power
69.4 / 100 composite
Steady, predictable earnings power — graded A–F vs. similar companies.

Company Description

Track Record

Showing latest 4 periods • Swipe for more
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue 1.35B 1.27B 1.30B 1.25B 1.28B 1.16B 1.24B 1.05B 1.08B 1.03B 970.64M 960.18M
Net Income 255.02M 261.82M 200.66M 184.09M 310.23M 231.36M 255.15M 41.75M 201.80M 185.86M 181.39M 206.10M
EPS 2.66 2.74 2.00 1.84 3.07 2.30 2.51 1.18 1.98 1.85 1.75 2.02
Free Cash Flow 430.26M 297.25M 336.74M 259.12M 393.30M 274.86M 214.14M 266.85M 272.93M 138.28M 114.44M 248.23M
FCF / Share 4.49 3.11 3.52 2.59 3.89 2.73 2.11 2.58 2.68 1.37 1.12 2.43
Operating CF 472.20M 327.25M 367.08M 318.58M 447.75M 343.85M 327.67M 352.20M 377.79M 360.06M 309.38M 361.55M
Total Assets 3.23B 3.13B 2.99B 2.70B 3.12B 2.94B 2.82B 2.87B 2.54B 2.32B 2.13B 1.98B
Total Debt 38.88M 46.99M 50.65M 50.94M 72.12M 81.14M 0 0 0 0 0 0
Cash & Equiv 701.89M 577.75M 817.97M 628.37M 1.23B 1.08B 805.59M 925.25M 634.37M 519.76M 534.86M 570.61M
Book Value 2.62B 2.48B 2.36B 2.25B 2.60B 2.43B 2.31B 2.19B 2.14B 1.97B 1.81B 1.71B
Return on Equity 0.10 0.11 0.09 0.08 0.12 0.10 0.11 0.02 0.09 0.09 0.10 0.12
DLB News
Dolby Laboratories Announces Leadership Transition
Aug 27, 2026 05:00 AM · prnewswire.com
Cinemo, Dolby, and SmashLabs Bring In-Car Immersive Gaming Experiences to the Next Level
Aug 21, 2026 02:00 AM · gurufocus.com
Dividend Champion, Contender, And Challenger Highlights: Week August 16
Aug 14, 2026 02:01 PM · seekingalpha.com
Assenagon Asset Management S.A. Has $5.48 Million Position in Dolby Laboratories $DLB
Aug 12, 2026 11:31 PM · defenseworld.net
Here's Why Dolby Laboratories (DLB) is a Strong Growth Stock
Aug 12, 2026 06:46 AM · zacks.com
CervoMed Announces Neflamapimod Awarded Innovation Passport Designation Under the UK Innovative Licensing and Access Pathway (ILAP) for Treatment of Dementia with Lewy Bodies (DLB)
Aug 04, 2026 01:15 AM · globenewswire.com
Can Dolby's Fiscal Q4 Growth Outlook Overcome Licensing Volatility?
Aug 03, 2026 07:11 AM · zacks.com
Is Dolby Stock Worth Buying as Growth Meets Near-Term Execution Risks?
Aug 03, 2026 07:01 AM · zacks.com
Why Dolby Labs Stock Popped Today
Jul 31, 2026 07:02 AM · fool.com
Dolby's Q3 Earnings Beat Estimates on Lower Operating Expenses
Jul 31, 2026 05:06 AM · zacks.com